SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-030126
Filing Date
2024-03-12
Accepted
2024-03-12 17:15:31
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clsd-20231231.htm   iXBRL 10-K 2539426
2 EX-10.31 clsd-ex10_31.htm EX-10.31 710192
3 EX-10.33 clsd-ex10_33.htm EX-10.33 44982
4 EX-10.35 clsd-ex10_35.htm EX-10.35 40367
5 EX-23.1 clsd-ex23_1.htm EX-23.1 13468
6 EX-31.1 clsd-ex31_1.htm EX-31.1 13519
7 EX-31.2 clsd-ex31_2.htm EX-31.2 13482
8 EX-32.1 clsd-ex32_1.htm EX-32.1 8940
9 EX-97.CLAWBACKPO clsd-ex97_clawbackpo.htm EX-97.CLAWBACKPO 53836
10 GRAPHIC img141503921_0.jpg GRAPHIC 35686
11 GRAPHIC img141503921_1.jpg GRAPHIC 46523
12 GRAPHIC img141503921_2.jpg GRAPHIC 163775
  Complete submission text file 0000950170-24-030126.txt   11211334

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clsd-20231231.xsd EX-101.SCH 1482791
83 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20231231_htm.xml XML 1539194
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37783 | Film No.: 24743354
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)